The view of European experts regarding health economics for medical nutrition in disease-related malnutrition

K. Freijer*, I. Lenoir-Wijnkoop, C.A. Russell, M.A. Koopmanschap, H.M. Kruizenga, S.K. Lhachimi, K. Norman, M.J.C. Nuijten, J.M.G.A. Schols

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Health-care systems are currently facing tremendous budget constraints resulting in growing pressure on decision makers and health-care providers to obtain the maximum possible health benefits of the resources available. Choices have to be made, and health economics can help in allocating limited health-care resources among unlimited wants and needs. Attempts to achieve cost reductions often focus on severe pathologies and chronic diseases as they commonly represent high health-care expenditures. In this context, awareness of the considerable financial burden caused by disease-related malnutrition (DRM) is lacking. Possibilities of reducing costs by optimising the management of DRM through medical nutrition will mostly not even be taken into account. During a European expert meeting, the total evaluation of medical nutrition was viewed and discussed. The aim of this meeting was to gain an experts' outline of the key issues relating to the health economic assessment of the use of medical nutrition. This article provides a summary of the observations per discussed item and describes the next steps suggested.

Original languageEnglish
Pages (from-to)539-545
Number of pages7
JournalEuropean Journal of Clinical Nutrition
Volume69
Issue number5
DOIs
Publication statusPublished - May 2015

Keywords

  • COST-EFFECTIVENESS
  • SUPPORT
  • METAANALYSIS
  • SUPPLEMENTS
  • TRIALS
  • STATEMENT
  • PROTEIN
  • DEVICES
  • IMPACT
  • DRUGS

Cite this